Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Biederman

Showing results (351-360 of 581) with videos related to

Pageof 59
Sort By:
The Journal of Clinical Psychiatry|May 3, 2006
Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidityThomas J Spencer, Stephen V Faraone, David Michelson, et al.
Journal of Autism and Developmental Disorders|January 23, 2013
Brief report: examining driving behavior in young adults with high functioning autism spectrum disorders: a pilot study using a driving simulation paradigmBryan Reimer, Ronna Fried, Bruce Mehler, et al.
Psychopharmacology|November 10, 2006
Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial dataJoseph Biederman, Thomas J Spencer, Jeffrey H Newcorn, et al.
The American Journal of Psychiatry|October 3, 2006
Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid?Stephen V Faraone, Joseph Biederman, Thomas Spencer, et al.
The Journal of Clinical Psychiatry|January 14, 2003
Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorderThomas Spencer, John H Heiligenstein, Joseph Biederman, et al.
CNS Spectrums|April 8, 2003
Does comorbid attention-deficit/hyperactivity disorder impact the clinical expression of pediatric obsessive-compulsive disorder?Daniel A Geller, Barbara Coffey, Stephen Faraone, et al.
The American Journal on Addictions|March 6, 2002
A family study of the high-risk children of opioid- and alcohol-dependent parentsTimothy E Wilens, Joseph Biederman, Elizabeth Bredin, et al.
Journal of Attention Disorders|February 9, 2018
Validation of the Expanded Versions of the Adult ADHD Self-Report Scale v1.1 Symptom Checklist and the Adult ADHD Investigator Symptom Rating ScaleMichael J Silverstein, Stephen V Faraone, Samuel Alperin, et al.
Journal of Child and Adolescent Psychopharmacology|July 26, 2003
Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?Daniel A Geller, Joseph Biederman, S Evelyn Stewart, et al.
Bipolar Disorders|May 26, 2017
Similar familial underpinnings for full and subsyndromal pediatric bipolar disorder: A familial risk analysisJanet Wozniak, Mai Uchida, Stephen V Faraone, et al.
Pageof 59

Showing results (351-360 of 581) with videos related to

Sort By:
Pageof 59
The Journal of Clinical Psychiatry|May 3, 2006
Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidityThomas J Spencer, Stephen V Faraone, David Michelson, et al.
Journal of Autism and Developmental Disorders|January 23, 2013
Brief report: examining driving behavior in young adults with high functioning autism spectrum disorders: a pilot study using a driving simulation paradigmBryan Reimer, Ronna Fried, Bruce Mehler, et al.
Psychopharmacology|November 10, 2006
Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial dataJoseph Biederman, Thomas J Spencer, Jeffrey H Newcorn, et al.
The American Journal of Psychiatry|October 3, 2006
Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid?Stephen V Faraone, Joseph Biederman, Thomas Spencer, et al.
The Journal of Clinical Psychiatry|January 14, 2003
Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorderThomas Spencer, John H Heiligenstein, Joseph Biederman, et al.
CNS Spectrums|April 8, 2003
Does comorbid attention-deficit/hyperactivity disorder impact the clinical expression of pediatric obsessive-compulsive disorder?Daniel A Geller, Barbara Coffey, Stephen Faraone, et al.
The American Journal on Addictions|March 6, 2002
A family study of the high-risk children of opioid- and alcohol-dependent parentsTimothy E Wilens, Joseph Biederman, Elizabeth Bredin, et al.
Journal of Attention Disorders|February 9, 2018
Validation of the Expanded Versions of the Adult ADHD Self-Report Scale v1.1 Symptom Checklist and the Adult ADHD Investigator Symptom Rating ScaleMichael J Silverstein, Stephen V Faraone, Samuel Alperin, et al.
Journal of Child and Adolescent Psychopharmacology|July 26, 2003
Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?Daniel A Geller, Joseph Biederman, S Evelyn Stewart, et al.
Bipolar Disorders|May 26, 2017
Similar familial underpinnings for full and subsyndromal pediatric bipolar disorder: A familial risk analysisJanet Wozniak, Mai Uchida, Stephen V Faraone, et al.
Pageof 59